{"title":"第七届欧洲神经科学论坛。","authors":"Anthony J Hannan","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The European Neuroscience--Seventh Biennial FENS Forum, held in Amsterdam, included topics covering new therapeutic developments in the field of neuroscience. This conference report highlights selected presentations on sodium channel inhibitors, ionotropic glutamate receptor antagonists, serotonin receptor modulators, and novel therapies for depression, pain and stroke. Investigational drugs discussed include ST-1936 (Sigma-Tau Industrie Farmaceutiche Riunite SpA), LY-392098 (Eli Lilly & Co) and Lu-AA21004 (H Lundbeck A/S/Takeda Pharmaceutical Co Ltd).</p>","PeriodicalId":55031,"journal":{"name":"Idrugs","volume":"13 9","pages":"607-9"},"PeriodicalIF":0.0000,"publicationDate":"2010-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"European Neuroscience--Seventh Biennial FENS Forum.\",\"authors\":\"Anthony J Hannan\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The European Neuroscience--Seventh Biennial FENS Forum, held in Amsterdam, included topics covering new therapeutic developments in the field of neuroscience. This conference report highlights selected presentations on sodium channel inhibitors, ionotropic glutamate receptor antagonists, serotonin receptor modulators, and novel therapies for depression, pain and stroke. Investigational drugs discussed include ST-1936 (Sigma-Tau Industrie Farmaceutiche Riunite SpA), LY-392098 (Eli Lilly & Co) and Lu-AA21004 (H Lundbeck A/S/Takeda Pharmaceutical Co Ltd).</p>\",\"PeriodicalId\":55031,\"journal\":{\"name\":\"Idrugs\",\"volume\":\"13 9\",\"pages\":\"607-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Idrugs\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Idrugs","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
欧洲神经科学-第七届双年展FENS论坛在阿姆斯特丹举行，主题涵盖神经科学领域的新治疗发展。本次会议报告重点介绍了钠通道抑制剂、嗜离子性谷氨酸受体拮抗剂、血清素受体调节剂以及抑郁症、疼痛和中风的新疗法。讨论的研究药物包括ST-1936 (Sigma-Tau Industrie Farmaceutiche Riunite SpA)、LY-392098 (Eli Lilly & Co)和Lu-AA21004 (H Lundbeck A/S/Takeda Pharmaceutical Co Ltd)。
European Neuroscience--Seventh Biennial FENS Forum.
The European Neuroscience--Seventh Biennial FENS Forum, held in Amsterdam, included topics covering new therapeutic developments in the field of neuroscience. This conference report highlights selected presentations on sodium channel inhibitors, ionotropic glutamate receptor antagonists, serotonin receptor modulators, and novel therapies for depression, pain and stroke. Investigational drugs discussed include ST-1936 (Sigma-Tau Industrie Farmaceutiche Riunite SpA), LY-392098 (Eli Lilly & Co) and Lu-AA21004 (H Lundbeck A/S/Takeda Pharmaceutical Co Ltd).
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
